Global Antidiabetics Market By Product, Insulin (Rapid-acting analog, Long-acting analog, Premixed insulin, Short-acting analog, Intermediate-acting insulin) Drug class (Alpha-glucosidase inhibitors, Biguanides, Sulphonylureas, GLP-1 (Glucagon-like peptide) agonists, DPP-IV (Dipeptidyl Peptidase) inhibitors, Meglitinides, SGLT-II (Sodium-Glucose Transport Proteins) inhibitors, Thiazolidinedione) By Route of administration (Oral, Subcutaneous, Intravenous) By Distribution Channel (Online Pharmacies, Hospital Pharmacies, Retail Pharmacies) By Diabetes Type (Type 1, Type 2) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: Aug 2024
- Report ID: 125817
- Number of Pages: 382
- Format:
-
keyboard_arrow_up
-
-
- AstraZeneca plc
- Bayer AG
- Takeda Pharmaceutical Company Limited
- Eli Lilly and Company
- Boehringer Ingelheim
- Bristol-Myers Squibb Company
- Pfizer, Inc.
- Johnson & Johnson Services Inc.
- Merck & Co. Inc
- Novartis AG
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible


